COUP-TFII sparks prostate cancer progression
Prostate cancer presents a dilemma for patients and the physicians who treat them. Which cancers are essentially indolent and present no risk and which are life threatening? Which can be watched and which need aggressive ...
Cancer
Nov 28, 2012 |
not rated yet |
0
|
Potential new technique for anticancer radiotherapy could provide alternative to brachytherapy
A promising new approach to treating solid tumors with radiation was highly efficacious and minimally toxic to healthy tissue in a mouse model of cancer, according to data published in Cancer Research, a journal of the Am ...
Cancer
Nov 15, 2012 |
not rated yet |
0
Compound in grapes, red wine could be key to fighting prostate cancer
Resveratrol, a compound found commonly in grape skins and red wine, has been shown to have several beneficial effects on human health, including cardiovascular health and stroke prevention. Now, a University ...
Cancer
Nov 10, 2012 |
5 / 5 (6) |
5
|
Mayo Clinic gets FDA approval for new imaging agent for recurrent prostate cancer
Mayo Clinic has received U.S. Food and Drug Administration approval to produce and administer Choline C 11 Injection, an imaging agent used during a positron emission tomography (PET) scan to help detect sites of recurrent ...
Cancer
Nov 08, 2012 |
5 / 5 (2) |
0
New targeted therapy for advanced prostate cancer shows anti-tumor activity in clinical trials
Few available treatment options exist once prostate cancer has spread to other parts of the body and has failed to respond to therapies that involve blocking the male hormone androgen. Patients with advanced, hormone-refractory ...
Cancer
Nov 07, 2012 |
not rated yet |
0
Cancer data in the 'cloud' could lead to more effective treatment
Storing music and photos on distant computers via "cloud" technology is nothing new. But Johns Hopkins researchers are now using this tactic to collect detailed information from thousands of cancer cell samples. ...
Cancer
Nov 06, 2012 |
not rated yet |
0
Prostate cancer prognosis hope
Cancer of the prostate – the most common male cancer in the UK – presents in two distinct ways: a low-risk type, which may never cause any symptoms, and a high-risk form that needs treatment to prevent it spreading to ...
Cancer
Oct 29, 2012 |
5 / 5 (2) |
0
|
New options for ease and accuracy in extraction of rare cells or separating blood
(Medical Xpress)—Using something called "inertial microfluidics," University of Cincinnati researchers are able to continuously and selectively collect rare cells, such as circulating tumor cells, based ...
Cancer
Oct 26, 2012 |
not rated yet |
0
|
New research uncovers promising new biomarker for aggressiveness of prostate cancer, implications for treatment
Research out of Roswell Park Cancer Institute (RPCI) supports the adoption of a new biomarker to measure the aggressiveness of primary prostate tumors. A team of investigators from three institutions, led by Shahriar Koochekpour, ...
Cancer
Oct 24, 2012 |
not rated yet |
0
Noninvasive assay monitored treatment response in patients with metastatic prostate cancer
Deciding the ideal treatment for patients with metastatic prostate cancer that stops responding to initial therapy could be guided by certain analyses of cancer cells isolated from the patients' blood, according to data published ...
Cancer
Oct 23, 2012 |
not rated yet |
0
|
Antioxidants in tea, fruit, veggies might fight prostate cancer: study
(HealthDay)—Prostate cancer patients who, before their diagnosis, routinely consumed hefty helpings of the flavonoid compounds found in plant-based foods and drinks may be at lower risk for the most aggressive ...
Cancer
Oct 17, 2012 |
4.5 / 5 (2) |
0
Stat5 predicts outcomes for prostate cancer patients after radical prostatectomy
Men who had high levels of the activated Stat5 protein in their prostate cancer after a radical prostatectomy were more likely to have a recurrence or die from the disease compared to men who had little to no presence of ...
Cancer
Oct 16, 2012 |
not rated yet |
1
Researchers reveal how Trop2 protein drives tumor growth in prostate, other epithelial cancers
(Medical Xpress)—Researchers led by Tanya Stoyanova and Dr. Owen Witte of UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have determined how a protein known as Trop2 drives the growth ...
Cancer
Oct 16, 2012 |
not rated yet |
0
|
Prostate cancer: Curcumin curbs metastases
Powdered turmeric has been used for centuries to treat osteoarthritis and other illnesses. Its active ingredient, curcumin, inhibits inflammatory reactions. A new study led by a research team at Ludwig-Maximilians-Universität ...
Cancer
Oct 12, 2012 |
5 / 5 (2) |
0
|
3-D model for lung cancer mimics the real thing
(Medical Xpress)—A new technique that allows scientists to grow lung cancer cells in three dimensions could accelerate discoveries for a type of cancer that has benefited little from scientific research ...
Cancer
Oct 11, 2012 |
4 / 5 (1) |
0
